7 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Unknown 7 |
Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stratified Therapy on Pediatric AAGN GlucoCorticoid - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis | Phase 4 | Unknown | Wang Mo | 200 | 2023-01-01 | 2023-08-01 |
| Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA Tofacitinib, Methotrexate - Granulomatosis With Polyangiitis | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 66 | 2021-07-01 | 2021-07-09 |
| Low-dose Glucocorticoid Vasculitis Induction Study Rituximab, Glucocorticoids - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis | Phase 4 | Unknown | Chiba University | 140 | 2014-10-01 | 2021-01-27 |
| Alemtuzumab for ANCA Associated Refractory Vasculitis Alemtuzumab - Vasculitis, Microscopic Polyangiitis | Phase 4 | Unknown | Cambridge University Hospitals NHS Foundation Trust | 24 | 2011-02-01 | 2011-07-29 |
| Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Anti-pandemic H1N1 influenza vaccine - Rheumatoid Arthritis, Spondyloarthritis | Phase 4 | Unknown | University of Sao Paulo | 5000 | 2010-04-01 | 2010-06-28 |
| CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors azathioprine, cyclophosphamide - Polyarteritis Nodosa, Microscopic Polyangiitis | Phase 4 | Unknown | Hospices Civils de Lyon | 124 | 1996-07-01 | 2006-11-16 |
| CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors azathioprine, cyclophosphamide - Churg-Strauss Syndrome | Phase 4 | Unknown | Hospices Civils de Lyon | 72 | 1996-07-01 | 2006-11-14 |
Granulomatosis with Polyangiitis (3) · Microscopic Polyangiitis (3) · Vasculitis (3) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Antiphospholipid Syndrome (1) · Arthritis, Juvenile (1) · Arthritis, Rheumatoid (1) · Churg-Strauss Syndrome (1) · Dermatomyositis (1) · Influenza, Human (1) · Lupus Erythematosus, Systemic (1) · Polyarteritis Nodosa (1) · Rheumatic Diseases (1) · Scleroderma, Systemic (1) · Sjogren's Syndrome (1)
Autoimmune Diseases (7) · Cardiovascular Diseases (7) · Immune System Diseases (7) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7) · Vascular Diseases (7) · Skin Diseases, Vascular (6) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (4) · Nervous System Diseases (4) · Respiratory Tract Diseases (4) · Vasculitis (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Cerebral Small Vessel Diseases (3)
Cyclophosphamide (3) · Azathioprine (2) · Glucocorticoids (2) · Rituximab (2) · Alemtuzumab (1) · Methotrexate (1) · Prednisolone (1) · tofacitinib (1)
Hospices Civils de Lyon (2) · Cambridge University Hospitals NHS Foundation Trust (1) · Chiba University (1) · Shanghai Zhongshan Hospital (1) · University of Sao Paulo (1) · Wang Mo (1)
China (2) · Switzerland (2) · Brazil (1) · Japan (1) · United Kingdom (1)
David RW Jayne, MD MRCP (1) · Hiroshi Nakajima, M.D., Ph.D (1) · Lindi Jiang, PhD (1)
PMID 25153486, PMID 18240234, PMID 21540203, PMID 21859696, PMID 22089462, PMID 22298793, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23123020, PMID 23525305, PMID 23590801, PMID 23818263, PMID 24961747, PMID 28968874, PMID 29247107, PMID 33164993, PMID 34061144, PMID 35365179, PMID 37734880
2009 (1)